DFTX
DFTX
CA24477V1058
Definium Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
166.309.000 103.916.000
60.0%
Operating Income -166.309.000 -103.916.000
60.0%
Pretax Income -183.793.000 -108.679.000
69.1%
Net Income Common Stockholders -183.793.000 -108.679.000
69.1%
-- --
--
-- --
--
ende